When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...

Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...